FATE THERAPEUTICS INC License Agreements
17 Contracts & Agreements
- License Agreement, dated April 9, 2020, by and between the Registrant and Dana-Farber Cancer Institute, Inc (Filed With SEC on February 28, 2022)
- Patent License Agreement by and between the Registrant and Max-Delbrck-Centrum fr Molekulare Medizin in der Helmholtz-Gemeinschaft, dated August 30, 2019 (Filed With SEC on February 24, 2021)
- License Agreement between the Registrant and The Scripps Research Institute, dated as of August 24, 2010 (Filed With SEC on February 24, 2021)
- License Agreement between the Registrant and The Scripps Research Institute, dated as of May 25, 2010 (Filed With SEC on February 24, 2021)
- License Agreement between the Registrant and The Scripps Research Institute, dated as of July 13, 2009 (Filed With SEC on February 24, 2021)
- Whitehead Institute for Biomedical Research Exclusive Patent License Agreement between the Registrant and the Whitehead Institute for Biomedical Research, dated as of February 24,... (Filed With SEC on February 24, 2021)
- Exclusive License Agreement by and between the Registrant and The J. David Gladstone Institutes, dated September 11, 2018 (Filed With SEC on November 1, 2018)
- Amended and Restated Exclusive License Agreement by and between the Registrant and Memorial Sloan Kettering Cancer Center, dated May 15, 2018 (Filed With SEC on August 6, 2018)
- LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and FATE THERAPEUTICS, INC. a Delaware corporation (Filed With SEC on March 12, 2015)
- LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and FATE THERAPEUTICS, INC. a Delaware corporation 1 (Filed With SEC on March 12, 2015)
- LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and FATE THERAPEUTICS, INC., a Delaware corporation (Filed With SEC on March 12, 2015)
- WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH and FATE THERAPEUTICS, INC. EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on March 12, 2015)
- Second Amendment to Restated License Agreement (Filed With SEC on August 14, 2013)
- First Amendment to Restated License Agreement (Filed With SEC on August 14, 2013)
- RESTATED LICENSE AGREEMENT (Filed With SEC on August 14, 2013)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 14, 2013)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN CHILDRENS MEDICAL CENTER CORPORATION AND FATETHERAPEUTICS, INC. (Filed With SEC on August 14, 2013)
